Cite
Perinodopril, an angiotensin converting enzyme inhibitor, attenuates experimental hepatic fibrosis
MLA
Eman Obaia, et al. “Perinodopril, an Angiotensin Converting Enzyme Inhibitor, Attenuates Experimental Hepatic Fibrosis.” Bulletin of Egyptian Society for Physiological Sciences, vol. 27, June 2007, pp. 381–92. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........08fb9d8488a605b46c56d2bb7b0e79bb&authtype=sso&custid=ns315887.
APA
Eman Obaia, Amira Hassouna, Heba Shawky, & Samar Marzouk. (2007). Perinodopril, an angiotensin converting enzyme inhibitor, attenuates experimental hepatic fibrosis. Bulletin of Egyptian Society for Physiological Sciences, 27, 381–392.
Chicago
Eman Obaia, Amira Hassouna, Heba Shawky, and Samar Marzouk. 2007. “Perinodopril, an Angiotensin Converting Enzyme Inhibitor, Attenuates Experimental Hepatic Fibrosis.” Bulletin of Egyptian Society for Physiological Sciences 27 (June): 381–92. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........08fb9d8488a605b46c56d2bb7b0e79bb&authtype=sso&custid=ns315887.